在 Elevance Health 的收益超出预期后，投资者增持了该公司的股份，估值为 954.3 亿美元。 Investors boost stakes in Elevance Health after it beat earnings forecasts, valued at $95.43 billion.

像牛津资产管理公司和Vulcan Value Partners这样的机构投资者增加了他们对美国主要医疗福利公司Elevance Health的股权. Institutional investors like Oxford Asset Management and Vulcan Value Partners have increased their stakes in Elevance Health, a major U.S. health benefits company. Elevance Health 最近公布的每股收益超过 11.97 美元，并被分析师评为“适度买入”，一致目标价为 509.44 美元。 Elevance Health recently surpassed earnings expectations, reporting $11.97 per share, and has been rated "Moderate Buy" by analysts with a consensus price target of $509.44. 该公司的市场上限为955.43亿美元。 The company's market cap stands at $95.43 billion.